The Claim

Photooxygenation-mediated myostatin inhibition irreversibly and catalytically inactivates myostatin protein, providing a therapeutic strategy for muscle atrophy.

Source: Development of functionalized peptides for efficient inhibition of myostatin by selective photooxygenation.

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Light-triggered chemical modification permanently disables the myostatin protein, which is known to limit muscle growth, thereby addressing muscle atrophy.

See the scientific wording

Myostatin inhibition via photooxygenation is proposed as a precedented strategy for muscle atrophy therapy, where the protein is irreversibly and catalytically inactivated by light-triggered chemical modification.

Why this might work

A specially designed molecule binds to myostatin, and when exposed to near-infrared light, it produces a chemical reaction that permanently damages myostatin, preventing it from blocking muscle growth.

Supported mechanismbased on 1 study

What the research says

1 study

  1. Study: Development of functionalized peptides for efficient inhibition of myostatin by selective photooxygenation.

    Scientists made a special peptide that, when hit with a specific kind of light, permanently shuts down a protein called myostatin that stops muscles from growing. This could help people with muscle-wasting diseases.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.